News and stories
Learn more about our work in Peru and the main news of the health sector
En el Día Internacional de Acción por la Salud de la Mujer, presentamos los resultados de una intervención del programa de Salud Mental que ha demostrado reducir la depresión en madres y gestantes de Lima Norte.
Data from Socios En Salud programs show that 10% of people affected by tuberculosis, HIV, among other key populations, are at risk of suicide.
Through a consultancy to the Ministry of Health, SES participated in the drafting of the policy document for people with severe mental disorders and psychosocial problems.
The U.S. National Institutes of Health decided to fund our research focused on the treatment of tuberculosis resistant to the drug isoniazid.
The U.S. National Institutes of Health decided to fund our research focused on the treatment of tuberculosis resistant to the drug isoniazid.
The World Health Organization (WHO) approved three new regimens for multidrug-resistant tuberculosis (MDR-TB) that were studied in the endTB clinical trial that Socios En Salud was part of.
The World Health Organization (WHO) has re-declared an international health emergency due to the outbreak of a new variant of this virus in African countries.
Socios En Salud was present at AIDS 2024, an event where the results of lenacapavir, a highly effective injectable for HIV prevention, were presented.
As part of its RINDE - TB project, Socios En Salud is committed to promoting capacity building in civil society working on tuberculosis, with an outreach in 12 countries in Latin America and the Caribbean.
2023 was a period of achievements and challenges for Socios En Salud. In this review of our activities, we show how our health programs strive each year to bring the cure for injustice everywhere.